Cambridge Healthtech Institute’s 2nd Annual

RNA as a Drug Target

Expanding the Boundaries of Druggable Targets

September 16-17, 2020


In the past year, the idea of targeting RNA directly with either a small molecule-like drug or with oligonucleotides has gone from an interesting idea to a viable business plan. It is expected that the FDA plans to make a decision on the first oral small molecule targeting splicing. Join us at the 2nd Annual RNA as a Drug Target conference, part of Discovery on Target, as we discuss not only the identification of specific and potent novel binders of RNA, but also the unique challenges that come with a novel drug target class.


Who should attend: Medicinal Chemists, Pharmacologists, Drug Discovery Directors.


Coverage will include, but is not limited to:                                        

  • Identifying appropriate target structures
  • Design principles for small molecules and oligonucleotides
  • Development of chemical probes for unique RNA elements
  • High-throughput techniques to enhance discovery
  • Applications of compounds that target RNA
  • Case studies of other modalities, RNAi, oligonucleotides to target RNA


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is February 26, 2020.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:

Mana Chandhok

Conference Producer

Cambridge Healthtech Institute

Phone: (+1) 781-972-1350



For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286